Glenmark Life Sciences informs about offer letter

09 Feb 2024 Evaluate
Glenmark Life Sciences has informed that DAM Capital Advisors (Manager to the Offer) has submitted a copy of Letter of Offer to the Public Shareholders of Glenmark Life Sciences (Target Company).

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

868.30 -12.05 (-1.37%)
19-Jan-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.50
Dr. Reddys Lab 1173.25
Cipla 1393.30
Zydus Lifesciences 873.45
Lupin 2179.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×